A carregar...
Membranoproliferative Glomerulonephritis Associated with Nivolumab Therapy
Nivolumab is an immune checkpoint inhibitor that targets programmed death-1 on T cells and is designed to amplify an immunologic reaction against cancer cells. However, upregulation of the immune system with checkpoint inhibition is nonspecific, and it can be associated with certain renal side effec...
Na minha lista:
| Publicado no: | Case Rep Nephrol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7060432/ https://ncbi.nlm.nih.gov/pubmed/32257470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/2638283 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|